Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) FCF Margin (2016 - 2025)

Historic FCF Margin for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to 29.66%.

  • Ascendis Pharma A's FCF Margin rose 797800.0% to 29.66% in Q4 2025 from the same period last year, while for Dec 2025 it was 7.85%, marking a year-over-year increase of 919900.0%. This contributed to the annual value of 7.48% for FY2025, which is 916900.0% up from last year.
  • Ascendis Pharma A's FCF Margin amounted to 29.66% in Q4 2025, which was up 797800.0% from 1.01% recorded in Q3 2025.
  • Over the past 5 years, Ascendis Pharma A's FCF Margin peaked at 29.66% during Q4 2025, and registered a low of 10921.62% during Q2 2021.
  • For the 5-year period, Ascendis Pharma A's FCF Margin averaged around 1787.45%, with its median value being 226.29% (2021).
  • Per our database at Business Quant, Ascendis Pharma A's FCF Margin crashed by -76757200bps in 2021 and then surged by 89627400bps in 2022.
  • Ascendis Pharma A's FCF Margin (Quarter) stood at 194.97% in 2021, then crashed by -209bps to 602.33% in 2022, then skyrocketed by 98bps to 14.05% in 2023, then tumbled by -257bps to 50.13% in 2024, then soared by 159bps to 29.66% in 2025.
  • Its FCF Margin stands at 29.66% for Q4 2025, versus 1.01% for Q3 2025 and 4.64% for Q2 2025.